Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of rhPTH(1-34) vs Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism
NCT02824718Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2017
- Primary completion
- May 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of teriparatide in Primary Hypoparathyroidism (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Plasma calcium concentration at 2 months. Started Jun 2017; status: completed.
02
Drugs
teriparatide
03
Conditions
Primary Hypoparathyroidism
Beyond the preview
Go deeper on NCT02824718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02824718.